Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Damien Goldberg, MD
Wolstan & Goldberg Eye Associates
Principal Investigator - Jodi Luchs, MD
South Shore Eye Center, LLP
Principal Investigator - John Sheppard, MD
Virginia Eye Consultants
Principal Investigator - Joseph Tauber, MD
Tauber Eye Center
Principal Investigator - Kelly Nichols, OD, PhD
UAB School of Optometry
Principal Investigator - Kenneth Sall, MD
Sall Research Medical Center
Principal Investigator - Marc Abrams, MD
Abrams Eye Center
Principal Investigator - Steven Rauchman, MD
North Valley Eye Medical Group
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Uab School of Optometry
Birmingham, Alabama, United States
- Sall Research Medical Center
Artesia, California, United States
- North Valley Eye Medical Group
Mission Hills, California, United States
- Wolstan & Goldberg Eye Associates
Torrance, California, United States
- Tauber Eye Center
Kansas City, Missouri, United States
- South Shore Eye Center, Llp
Wantagh, New York, United States
- Abrams Eye Center
Cleveland, Ohio, United States
- Virginia Eye Consultants
Norfolk, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2014
- Primary completion
- 31 Dec 2015
- Completion
- 30 Jun 2016
- Last update posted
- 11 Jan 2021
- Registered enrollment
- 206
- Registry id
- NCT02218489
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.